Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2006 1
2007 2
2008 3
2009 2
2010 2
2011 4
2012 4
2013 3
2014 4
2015 2
2016 5
2017 5
2018 4
2019 3
2020 4
2021 3
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
Domingos-Pereira S, Sathiyanadan K, Polak L, Haefliger JA, Schmittnaegel M, Ries CH, Jichlinski P, Roth B, Derré L, Nardelli-Haefliger D. Domingos-Pereira S, et al. Among authors: nardelli haefliger d. Int J Mol Sci. 2022 Dec 21;24(1):123. doi: 10.3390/ijms24010123. Int J Mol Sci. 2022. PMID: 36613562 Free PMC article.
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L, Lucca I, Cesson V, Valerio M, Cerantola Y, Burruni R, Fritschi U, Gharbi D, Bobst M, Legris AS, Dartiguenave F, Jichlinski P, Nardelli-Haefliger D. Derré L, et al. Among authors: nardelli haefliger d. Eur Urol Focus. 2020 Mar 15;6(2):280-283. doi: 10.1016/j.euf.2018.09.003. Epub 2018 Sep 13. Eur Urol Focus. 2020. PMID: 30219710
Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth.
Sathiyanadan K, Alonso F, Domingos-Pereira S, Santoro T, Hamard L, Cesson V, Meda P, Nardelli-Haefliger D, Haefliger JA. Sathiyanadan K, et al. Among authors: nardelli haefliger d. Int J Mol Sci. 2022 Mar 8;23(6):2930. doi: 10.3390/ijms23062930. Int J Mol Sci. 2022. PMID: 35328350 Free PMC article.
Immunotherapeutic strategies for bladder cancer.
Chevalier MF, Nardelli-Haefliger D, Domingos-Pereira S, Jichlinski P, Derré L. Chevalier MF, et al. Among authors: nardelli haefliger d. Hum Vaccin Immunother. 2014;10(4):977-81. doi: 10.4161/hv.27621. Epub 2014 Jan 2. Hum Vaccin Immunother. 2014. PMID: 24384699 Free PMC article.
SITC 26th annual meeting--summary.
Romano E, Nardelli-Haefliger D, Donda A, Corgnac S, Romero P. Romano E, et al. Among authors: nardelli haefliger d. J Transl Med. 2012 May 23;10:105. doi: 10.1186/1479-5876-10-105. J Transl Med. 2012. PMID: 22620286 Free PMC article.
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.
Derré L, Lucca I, Cesson V, Bohner P, Crettenand F, Rodrigues-Dias SC, Dartiguenave F, Masnada A, Teixeira-Pereira C, Benmerzoug S, Chevalier MF, Domingos-Pereira S, Nguyen S, Polak L, Schneider AK, Jichlinski P, Roth B, Nardelli-Haefliger D. Derré L, et al. Among authors: nardelli haefliger d. J Immunother Cancer. 2023 Dec 14;11(12):e008020. doi: 10.1136/jitc-2023-008020. J Immunother Cancer. 2023. PMID: 38101861 Free PMC article.
57 results